Children with severe Osteogenesis imperfecta and short stature present on average with normal IGF-I and IGFBP-3

Insights

Children with Osteogenesis Imperfecta (OI) show Insulin-like Growth Factor-I (IGF-I) and IGF Binding Protein-3 (IGFBP-3) levels in the lower normal range. These growth factor levels do not significantly differ between OI types.

Area of Science:

  • Pediatric Endocrinology
  • Skeletal Dysplasias
  • Growth Factor Research

Background:

  • Osteogenesis Imperfecta (OI) is a genetic disorder causing bone fragility and growth impairment.
  • Limited data exists on Insulin-like Growth Factor-I (IGF-I) and IGF Binding Protein-3 (IGFBP-3) levels in children with OI.
  • Understanding these growth factors is crucial for managing OI-related growth disturbances.

Purpose of the Study:

  • To investigate IGF-I and IGFBP-3 levels in children diagnosed with various types of Osteogenesis Imperfecta.
  • To determine if OI severity, categorized by type, correlates with differences in IGF-I and IGFBP-3 levels.

Main Methods:

  • Retrospective cross-sectional study involving 60 pediatric patients with OI.
  • Assessed serum levels of IGF-I and IGFBP-3.
  • Compared growth factor levels between different types of OI, specifically type 3 and type 4.

Main Results:

  • Mean IGF-I levels were found in the lower normal range (137.4±109.1 μg/L).
  • Mean IGFBP-3 levels were within the normal range (3.105±1.175 mg/L).
  • No statistically significant differences in IGF-I or IGFBP-3 levels were observed between children with OI type 3 and type 4.

Conclusions:

  • Children with Osteogenesis Imperfecta, regardless of severity, exhibit IGF-I and IGFBP-3 levels in the lower end of the normal spectrum.
  • The specific type of OI does not appear to significantly impact IGF-I and IGFBP-3 levels in the studied pediatric cohort.
Abstract

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
6.8K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.2K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.7K
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
4.0K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
12.6K
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
14.2K